Description

Ecsemevista (exemestane) Coated Tablets 25 mg. №30

Ingredients:

Each coated tablet contains 25 mg of exemestane as the active ingredient.

Dosage:

The recommended dosage is one 25 mg tablet taken orally once daily after a meal.

Indications:

Ecsemevista (exemestane) is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer.

Contraindications:

Do not use Ecsemevista if you are pregnant, breastfeeding, or allergic to exemestane.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Exemestane, the active ingredient in Ecsemevista, is an aromatase inhibitor that works by reducing the production of estrogen in the body. This mechanism of action has been shown to be effective in reducing the risk of breast cancer recurrence in postmenopausal women.

A study published in the New England Journal of Medicine demonstrated that exemestane significantly improved disease-free survival in postmenopausal women with early breast cancer compared to tamoxifen.

Additional Information:

• Store at room temperature away from moisture and heat.
• Keep out of reach of children.
• Consult your healthcare provider before using Ecsemevista.